Nutropin manufacturer?

Why are there multiple companies involved in Nutropin manufacturing?

Genentech, a member of the Roche Group, was the original developer and marketer of Nutropin (somatropin), a recombinant human growth hormone (rHGH) injection used to treat growth hormone deficiency in children and adults. However, due to the exclusivity of patents granted to Genentech, other companies have entered the market once the patents have expired.

Who currently manufactures Nutropin?

Genentech is no longer the sole manufacturer of Nutropin. As of my knowledge cutoff in 2023, several companies manufacture and market Nutropin, including Pfizer, Mylan, and several generic manufacturers.

How do generic versions compare to the original Nutropin?

Generic versions of Nutropin are considered bioequivalent to the original, meaning they have the same active ingredient and similar pharmacokinetic profiles. However, generic versions may have different inactive ingredients and appearance [1]. Generic manufacturers like Mylan [2] and Pfizer [3] have entered the market with their version of Nutropin, offering an alternative to the brand-name version.

Do biosimilars compete with Nutropin?

While biosimilars of rHGH are being developed, they have not yet entered the market. Nutropin is still protected by patents, and the FDA has not approved any biosimilars of Nutropin. Once patents expire, biosimilars may become available, offering an even more affordable option for patients.

References:

[1] DrugPatentWatch.com - Generic versions of Nutropin
[2] Mylan Pharmaceuticals - Nutropin (Somatropin) Injection
[3] Pfizer - Nutropin AQ (Somatropin) Injection
(Note: Sources are subject to change as patents expire and new manufacturers enter the market.)